The global dialysis market in 2026 is valued at approximately $128.36 billion, dominated by several Large Dialysis Organizations (LDOs). Fresenius Medical Care and DaVita Inc. continue to hold a majority share of the U.S. and European markets, though they have transitioned from "real estate companies" to "integrated kidney care providers." They now offer everything from laboratory services and pharmacy support to transplant coordination.
The fastest-growing segment is in the Asia-Pacific region, where countries like China and India are rapidly expanding their network of subsidized centers. Emerging players in 2026 include B. Braun, Baxter International, and specialized tech firms like Nipro, which are challenging the giants by providing more affordable, "plug-and-play" dialysis machines designed for smaller, community-based clinics in developing economies.